GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

Q1 2022 GlaxoSmithKline PLC Earnings Call Transcript

Apr 27, 2022 / 11:00AM GMT
Release Date Price: $46.72 (+2.37%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Analyst Call for the GSK First Quarter 2022 Results. I will now hand you over to Nick Stone, Head of Global Investor Relations, who will introduce today's session.

Nick Stone

Thank you, operator. Hello, everyone. Welcome to our Q1 2022 conference call and webcast for investors and analysts. The presentation was posted to gsk.com, and it was also sent by e-mail to our distribution list earlier today.

Please turn to Slide 2. This is the usual safe harbor statement, and we'll be making comments on our performance using constant exchange rates, or CER, unless otherwise stated.

Please turn to Slide 3. This is today's agenda, where we will plan to cover all aspects of our Q1 2022 results. The presentation will last approximately 25 minutes with a further 35 minutes for questions. (Operator Instructions)

Today, our speakers are Emma Walmsley; Luke Miels; Deborah Waterhouse; Brian McNamara; and Iain Mackay. The Q&A portion of the call will be joined by Hal Barron; Roger Connor; and David

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot